Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial

IMPORTANCE: Azithromycin has been hypothesized to have activity against SARS-CoV-2. OBJECTIVE: To determine whether oral azithromycin in outpatients with SARS-CoV-2 infection leads to absence of self-reported COVID-19 symptoms at day 14. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial o...

詳細記述

保存先:
書誌詳細
出版年:JAMA
主要な著者: Oldenburg, Catherine E., Pinsky, Benjamin A., Brogdon, Jessica, Chen, Cindi, Ruder, Kevin, Zhong, Lina, Nyatigo, Fanice, Cook, Catherine A., Hinterwirth, Armin, Lebas, Elodie, Redd, Travis, Porco, Travis C., Lietman, Thomas M., Arnold, Benjamin F., Doan, Thuy
フォーマット: Artigo
言語:Inglês
出版事項: American Medical Association 2021
主題:
Original Investigation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285753/
https://ncbi.nlm.nih.gov/pubmed/34269813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2021.11517
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料